The burden of acute coronary syndrome in Canada

The burden of acute coronary syndrome: The second leading cause of death in Canada

Tim Wilsdon
Life Sciences | Pharmaceuticals

CRA was commissioned by AstraZeneca to investigate the economic and societal burden associated with Acute Coronary Syndrome (ACS) in Canada. This short paper represents a summary of the full report.

Download PDF